Immunoassay detection of drugs in racing horses. IX. Detection of detomidine in equine blood and urine by radioimmunoassay.

The research article shows the development of a method using 125I radioimmunoassay to detect the presence of a potent sedative, detomidine, in equine blood and urine, which contributes to detecting illegal drugs in performance horses.

Development of a New Detection Method

• The research focuses on detomidine, a potent non-narcotic sedative which is being considered for approval for veterinary use in the USA.
• No effective screening method for detecting detomidine in horses previously existed. The researchers sought to fill this gap by designing a radioimmunoassay that uses an iodine isotope (125I) for detecting the presence of detomidine in equine blood and urine.
• This detection method is being proposed as a part of a wider set of tests for identifying the use of illegal drugs in performance horses.

Performance of the New Method and Its Selectivity

• The test was designed to show minimal cross-reactivity with other substances like acepromazine, epinephrine, haloperidol, or promazine, thereby ensuring its selectivity.
• However, the assay shows some limited cross-reactivity with xylazine, a substance that is pharmacodynamically similar to detomidine.

Detection Thresholds and Elimination Rates

• The detection method worked on a low concentration level of detomidine, being capable of identifying the substance when it was present at a level of approximately 2 ng/ml.
• The research also suggested that detomidine follows a first-order elimination from the horse’s system, dependent on the administered dose.
• ON administering 30 mg per horse, the plasma levels of detomidine reached a peak within 30 minutes and then reduced by half in the next 25 minutes.
• It was observed that even low doses (0.5 mg/horse) could be detected in the blood and urine for short periods using this test.

Discussions and Implications

• The study indicates that diuresis – an increased urine production – can occur as a result of administering clinical doses of detomidine. The research accounted for this impact in the analysis of urine samples.
• With the help of the newly developed method, detecting the presence of up to 30 mg/horse of detomidine in equine urine is possible for up to 8 hours post IV injection.
• The test can be used by research scientists and forensic analysts for establishing guidelines and controls for administering detomidine to performance horses and ensuring compliance with these guidelines.